Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Zinc Sulfate for the Treatment of High Risk Cervical HPV Versus Placebo

NCT03404310 is registered in ClinicalTrials.gov with Corewell Health West as lead sponsor.

NCT NCT03404310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03404310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Zinc Sulfate for the Treatment of High Risk Cervical HPV Versus Placebo
Lead sponsor
Corewell Health West
Phase
Not applicable
Overall status
Terminated
Start date
October 24, 2017
Completion date
June 28, 2019
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus